SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMGEN
AMGN 296.30-0.7%Nov 3 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Nathan L. who wrote (13)4/27/1996 2:37:00 AM
From: Craig Slotoroff   of 42
 
Nathan, I think Amgen is a great long term buy. I would look to buy at 54-55 with a max purchase price at 56. If you look at the major holdings of most of the mutual funds out there, you see Amgen as a large part of their holdings. I don't have any info on Amgen's R&D, but I think that Lepton will have a positive effect on Amgen's future earnings. Lepto (spelling)is a protein that is supposed to effect weight control. I don't think any one knows what role lepton plays in weight control, but there seems to be a connection. A company called interneuron is trying to get a patent on the lepton receptor, it's to early to tell how this will effect Amgen. No matter what, I think Amgen is a great long term investment. In fact I just bought more about two weeks ago at about 54. I also like Chiron, but I think it is expensive. I am very interested in Vasomedical. They have a patent on a noninvasive angina treatment called EECP. The studies that I have seen look very promising. I think this company is still pretty unknown, and I think the stock is very cheap. I bought in at 1.78 per share. It has since gone up to about 2 per share and closed today at 1.93. The great news about this company is that they just shipped out their first EECP machines this month. I think this company has great promise. Another biotech companey that I am looking at is Biocontrol. I am still doing research on the company, but what I have found so far seems ok. Biocontrol is supposed to have technology for glucose monitering without needing to take blood samples. If this tech gets FDA approval, and works well, then this stock will take off. Also Biocontrol has an Aids treatment, but I don't know much about it. If you don't mind a tech stock check out MUEI, it's a great short term buy. I just bought a few thousand shares. They make computers,and are a subsidery of MU. This stock is still near it's 52 week low, and has a 52 week high of 29. I think this stock will get up to at least 17. Only problem is that the stock tends to move with MU. I think the potential gains with this stock far out weights the risk. Well good luck, and at least check out Vasomedical. I think they have a great product, and am looking to place more money there.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext